Energy and Commerce Committee
- Referred To
Introduced: Jun 23, 2025
Latest action date: Jun 23, 2025
Latest development
Referred to the House Committee on Energy and Commerce.
Civixly approval
No ratings yet
Not enough ratings yet. Public approval appears at 5+ ratings.
Status detail: The most advanced recorded stage is committee consideration.
Plain-language overview
Safer Response Act of 2025
This bill reauthorizes through FY2030 and expands grants to government entities to provide first responders with opioid overdose reversal drugs (e.g., naloxone) and related training. The grant program is administered by the Substance Abuse and Mental Health Services Administration.
The bill expands the program to include treatment and training for overdoses from other drugs besides opioids (current law limits the program to addressing opioid overdoses). Also, the bill expands the program to more generally include treatments with drugs or devices that are legally marketed under applicable law (current law limits the program to drugs or devices that are officially approved or cleared by the Food and Drug Administration).
Official summary from Congress.gov.
Civixly topics
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Health
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Oct 12, 2026.
Newest action first. Action language comes from the official Congress.gov record.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Introduced in House
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
0 comments across 0 threads
Loading comments...